Actively Recruiting
Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments
Led by Kaohsiung Veterans General Hospital. · Updated on 2025-05-08
90
Participants Needed
1
Research Sites
98 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to evaluate the efficacy and safety of Remimazolam, either used alone or in combination with Propofol, for moderate sedation anesthesia during endoscopic therapies or examinations. Additionally, it seeks to explore whether their combination can further enhance the quality of patient anesthesia and recovery outcomes.
CONDITIONS
Official Title
Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects are between 20-80 years old.
- Anesthesiologists rated ASA as between I and III.
- Patients undergoing upper gastrointestinal endoscopic examination or therapy.
You will not qualify if you...
- Allergy to Propofol, Remimazolam, or opioid medications.
- Emergency surgery.
- Pregnancy.
- History of malignant hyperthermia.
- Impaired liver or kidney function.
- Airway difficulties due to pharyngeal tumors.
- Refusal to participate.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan, 81362
Actively Recruiting
Research Team
Y
Yuan-Yi Chia, M.D
CONTACT
C
Chen-Hsiu Chen, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here